Stockman Wealth Management Inc. Has $1.52 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

Share on StockTwits

Stockman Wealth Management Inc. lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 6.7% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,550 shares of the company’s stock after selling 829 shares during the period. Stockman Wealth Management Inc.’s holdings in Johnson & Johnson were worth $1,515,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the company. Exchange Traded Concepts LLC acquired a new position in Johnson & Johnson in the 4th quarter worth about $31,000. University of Texas Texas AM Investment Managment Co. acquired a new position in Johnson & Johnson in the 4th quarter worth about $31,000. Advocacy Wealth Management Services LLC increased its holdings in Johnson & Johnson by 38.2% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 300 shares of the company’s stock worth $39,000 after purchasing an additional 83 shares in the last quarter. Lion Street Advisors LLC acquired a new position in Johnson & Johnson in the 1st quarter worth about $45,000. Finally, Joseph P. Lucia & Associates LLC increased its holdings in Johnson & Johnson by 50.8% in the 1st quarter. Joseph P. Lucia & Associates LLC now owns 374 shares of the company’s stock worth $49,000 after purchasing an additional 126 shares in the last quarter. 67.66% of the stock is owned by institutional investors.

In other Johnson & Johnson news, Director William D. Perez bought 500 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were bought at an average price of $127.69 per share, for a total transaction of $63,845.00. Following the transaction, the director now directly owns 16,030 shares in the company, valued at $2,046,870.70. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is owned by corporate insiders.

Shares of JNJ stock opened at $144.37 on Friday. Johnson & Johnson has a 1-year low of $109.16 and a 1-year high of $157.00. The company has a current ratio of 1.31, a quick ratio of 1.05 and a debt-to-equity ratio of 0.41. The stock has a 50-day moving average of $146.81 and a 200-day moving average of $142.30. The stock has a market cap of $386.52 billion, a price-to-earnings ratio of 16.52, a PEG ratio of 3.19 and a beta of 0.71.

Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Tuesday, April 14th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.03 by $0.27. Johnson & Johnson had a return on equity of 39.71% and a net margin of 24.47%. The company had revenue of $20.69 billion for the quarter, compared to analyst estimates of $19.48 billion. During the same quarter in the prior year, the company earned $2.10 EPS. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. Sell-side analysts forecast that Johnson & Johnson will post 7.68 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 9th. Investors of record on Tuesday, May 26th will be given a dividend of $1.01 per share. This is a positive change from Johnson & Johnson’s previous quarterly dividend of $0.95. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $4.04 annualized dividend and a dividend yield of 2.80%. Johnson & Johnson’s dividend payout ratio is presently 43.78%.

A number of brokerages have issued reports on JNJ. Credit Suisse Group reaffirmed a “buy” rating and issued a $161.00 target price on shares of Johnson & Johnson in a report on Tuesday, April 28th. Stifel Nicolaus upped their target price on Johnson & Johnson from $140.00 to $155.00 and gave the stock a “hold” rating in a report on Wednesday, April 15th. Bank of America raised Johnson & Johnson from a “neutral” rating to a “buy” rating and upped their target price for the stock from $150.00 to $175.00 in a report on Wednesday, April 22nd. Morgan Stanley upped their target price on Johnson & Johnson from $160.00 to $170.00 and gave the stock an “overweight” rating in a report on Wednesday, April 29th. Finally, Wells Fargo & Co raised Johnson & Johnson to a “hold” rating in a research note on Wednesday, April 22nd. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $163.47.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Featured Article: Understanding the Price to Earnings Ratio (PE)

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

AE Wealth Management LLC Invests $384,000 in Sailpoint Technologies Holdings Inc
AE Wealth Management LLC Invests $384,000 in Sailpoint Technologies Holdings Inc
Johnson & Johnson  Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
Johnson & Johnson Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank
Brooktree Capital Management Has $4.25 Million Stock Position in Johnson & Johnson
Brooktree Capital Management Has $4.25 Million Stock Position in Johnson & Johnson
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Holdings in Wayfair Inc
Zurcher Kantonalbank Zurich Cantonalbank Boosts Stock Holdings in Wayfair Inc
Zurcher Kantonalbank Zurich Cantonalbank Grows Position in Coupa Software Inc
Zurcher Kantonalbank Zurich Cantonalbank Grows Position in Coupa Software Inc
First Trust Advisors LP Acquires 108,318 Shares of Dynatrace
First Trust Advisors LP Acquires 108,318 Shares of Dynatrace


© 2006-2020 Ticker Report